Farms.com Home   News

Animal Health Week emphasizes responsible use of antibiotics

Ottawa, ON - Canadian Food Inspection Agency

The Canadian Food Inspection Agency (CFIA) and the Canadian Veterinary Medical Association (CVMA) would like to recognize Animal Health Week by drawing attention to the important role played by veterinarians in keeping animals, and, in turn, humans, healthy through the appropriate use of antibiotics.

This year's Animal Health Week theme is "Our Role, Our Responsibility." The CFIA and its veterinarians understand that these drugs should be administered exactly as prescribed in order to preserve their effectiveness as well as protect animal and livestock health. Their potential misuse contributes to the development of resistant bacteria which poses a risk to people and animals. The fight against antimicrobial resistance is one of the priorities of the World Organisation for Animal Health (OIE) and its member countries, including Canada.

The CVMA encourages all animal owners to talk with their veterinarian for advice about their pet's health as well as the appropriate and responsible use of antibiotics.

Source: CFIA


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.